Literature DB >> 26700611

Beyond the opportunities of SDG 3: the risk for the NCDs agenda.

Pedro Ordunez1, Norm Rc Campbell2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26700611     DOI： 10.1016/S2213-8587(15)00488-X

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  5 in total

1.  Everyday disease diplomacy: an ethnographic study of diabetes self-care in Vietnam.

Authors:  Tine M Gammeltoft; Thị Huyền Diệu Bùi; Thị Kim Dung Vũ; Đức Anh Vũ; Thị Ái Nguyễn; Minh Hiếu Lê
Journal:  BMC Public Health       Date:  2022-04-25       Impact factor: 4.135

2.  Monitoring and evaluation framework for hypertension programs. A collaboration between the Pan American Health Organization and World Hypertension League.

Authors:  Norm R C Campbell; Pedro Ordunez; Donald J DiPette; Gloria P Giraldo; Sonia Y Angell; Marc G Jaffe; Dan Lackland; Ramón Martinez; Yamilé Valdez; Javier I Maldonado Figueredo; Melanie Paccot; Maria J Santana; Paul K Whelton
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-22       Impact factor: 3.738

Review 3.  Global Shifts in Cardiovascular Disease, the Epidemiologic Transition, and Other Contributing Factors: Toward a New Practice of Global Health Cardiology.

Authors:  Walter Mendoza; J Jaime Miranda
Journal:  Cardiol Clin       Date:  2017-02       Impact factor: 2.213

4.  Implementing standardized performance indicators to improve hypertension control at both the population and healthcare organization levels.

Authors:  Norm Campbell; Pedro Ordunez; Marc G Jaffe; Marcelo Orias; Donald J DiPette; Pragna Patel; Nadia Khan; Oyere Onuma; Daniel T Lackland
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-02-13       Impact factor: 3.738

Review 5.  Non-communicable diseases control in China and Japan.

Authors:  Fei Wu; Hiroto Narimatsu; Xiaoqiang Li; Sho Nakamura; Ri Sho; Genming Zhao; Yoshinori Nakata; Wanghong Xu
Journal:  Global Health       Date:  2017-12-20       Impact factor: 4.185
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.